TrianglePUBLICATIONS · 28211941
Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer
- Publication date
- 2017 Jun 15
- First author
- Katzenstein HM
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Katzenstein HM
- type
- Author
- name
- Furman WL
- type
- Author
- name
- Malogolowkin MH
- type
- Author
- name
- Krailo MD
- type
- Author
- name
- McCarville MB
- type
- Author
- name
- Towbin AJ
- type
- Author
- name
- Tiao GM
- type
- Author
- name
- Finegold MJ
- type
- Author
- name
- Ranganathan S
- type
- Author
- name
- Dunn SP
- type
- Author
- name
- Langham MR
- type
- Author
- name
- McGahren ED
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Katzenstein HM
- type
- Author
- name
- Furman WL
- type
- Author
- name
- Malogolowkin MH
- type
- Author
- name
- Krailo MD
- type
- Author
- name
- McCarville MB
- type
- Author
- name
- Towbin AJ
- type
- Author
- name
- Tiao GM
- type
- Author
- name
- Finegold MJ
- type
- Author
- name
- Ranganathan S
- type
- Author
- name
- Dunn SP
- type
- Author
- name
- Langham MR
- type
- Author
- name
- McGahren ED
- type
- Author
- bibliography ids
- nci-bib-d97d5b189e94710e66073c9b
- book metadata
- content sha256
- 6e686079167aa707d73b840b3f5b4410324768dde43177036523c1a03c99fb31
- document type
- citation
- dois
- 10.1002/cncr.30591
- electronic publication date
- display
- 2017 Feb 17
- precision
- day
- year
- 2017
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:28211941
- immutable id
- pubmed:28211941@6e686079167aa707d73b840b3f5b4410324768dde43177036523c1a03c99fb31
- journal
- abbreviation
- Cancer
- issn electronic
- 1097-0142
- issn print
- 0008-543X
- issue
- 12
- name
- Cancer
- nlm unique id
- 0374236
- pages
- 2360-2367
- volume
- 123
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 28211941
- provenance
- batch id
- 7a1288ac8bb5f9826304
- provider
- NCBI PubMed ESummary
- record sha256
- 90f712ddfad7ca593d64ac2270f2bdd27f8f15857bce3950988eb263943a88e1
- response sha256
- 0e879bec8c19d1cfda5629dca8745b04155d18cf54361825d4c070aebad2984d
- retrieved at
- 2026-09-09T23:47:23.138359+00:00
- publication date
- display
- 2017 Jun 15
- precision
- day
- year
- 2017
- publication types
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee.
Preserved source evidence · Not medical advice